- Home
- SGHT vs SMTI Comparison
SGHT vs SMTI Comparison
Compare SGHT & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGHT
- SMTI
- Stock Information
- Founded
- SGHT 2011
- SMTI 1982
- Country
- SGHT United States
- SMTI United States
- Employees
- SGHT N/A
- SMTI N/A
- Industry
- SGHT Medical Specialities
- SMTI Medical/Dental Instruments
- Sector
- SGHT Health Care
- SMTI Health Care
- Exchange
- SGHT Nasdaq
- SMTI Nasdaq
- Market Cap
- SGHT 222.3M
- SMTI 252.1M
- IPO Year
- SGHT 2021
- SMTI N/A
- Fundamental
- Price
- SGHT $3.44
- SMTI $29.84
- Analyst Decision
- SGHT Buy
- SMTI Strong Buy
- Analyst Count
- SGHT 8
- SMTI 2
- Target Price
- SGHT $4.01
- SMTI $49.50
- AVG Volume (30 Days)
- SGHT 164.1K
- SMTI 51.8K
- Earning Date
- SGHT 07-31-2025
- SMTI 08-11-2025
- Dividend Yield
- SGHT N/A
- SMTI N/A
- EPS Growth
- SGHT N/A
- SMTI N/A
- EPS
- SGHT N/A
- SMTI N/A
- Revenue
- SGHT $78,109,000.00
- SMTI $91,569,883.00
- Revenue This Year
- SGHT N/A
- SMTI $23.53
- Revenue Next Year
- SGHT $11.60
- SMTI $5.93
- P/E Ratio
- SGHT N/A
- SMTI N/A
- Revenue Growth
- SGHT N/A
- SMTI 34.65
- 52 Week Low
- SGHT $2.03
- SMTI $25.86
- 52 Week High
- SGHT $8.45
- SMTI $39.08
- Technical
- Relative Strength Index (RSI)
- SGHT 37.27
- SMTI 53.37
- Support Level
- SGHT $3.36
- SMTI $29.80
- Resistance Level
- SGHT $4.33
- SMTI $30.94
- Average True Range (ATR)
- SGHT 0.26
- SMTI 1.07
- MACD
- SGHT -0.13
- SMTI 0.29
- Stochastic Oscillator
- SGHT 6.39
- SMTI 73.17
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.